Allelica to provide multi-ancestry polygenic risk score to Baylor College of Medicine for clinical implementation

Baylor College of Medicine and Allelica, a life sciences company that develops and commercializes clinical genetic tests for healthcare and pharmaceutical industries, have announced a strategic collaboration to integrate clinical, multi-ancestry polygenic risk score (PRS) testing into BCM's extensive patient services portfolio. 

"PRS are of high interest to our clinical partners. We've been working closely with Allelica to ensure a robust analytical framework that takes into account the diversity of our patient population," said Dr. Eric Venner, Associate Professor and Director of Clinical Informatics at the BCM Human Genome Sequencing Center.